Abstract
Living donor lobar lung transplantation (LDLLT) was originally developed in the early 1990s, in response to the growing number of patients who were dying while awaiting suitable cadaveric donors for lung transplantation. The procedure involves bilateral lung transplantation using the right lower lobe from one living donor to replace the right lung of the recipient, and the left lower lobe from another living donor to replace the left lung. Because both of the patient’s lungs are replaced by lobes from healthy donors, our early experience was confined to children and young adults with cystic fibrosis who, by virtue of their small size, were predicted to receive adequate pulmonary reserve after receiving only two pulmonary lobes. In order to minimize ethical issues regarding the risks of subjecting two healthy donors to a lobectomy for each transplant, only parents or siblings were originally considered as potential donors. Once successful recipient and donor outcomes and safety were established, the use of living lobar lung transplantation expanded to include recipients with a wide range of pulmonary diseases, including other suppurative diseases of the lung, as well as pulmonary hypertension, pulmonary fibrosis, and pulmonary obstructive disease. Criteria for lung donation have expanded as well. Whereas the number of living donor lung transplants has decreased in the US due to the success of the lung allocation scoring system implemented by the Organ Procurement and Transplantation Network in 2005, its use has expanded in countries like Japan, where waiting times for cadaveric lungs remain exceptionally long.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Starnes VA, Barr ML, Cohen RG. Lobar transplantation: indications, technique, and outcome. J Thorac Cardiovasc Surg. 1994;108:403.
Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edwards LB, et al. Development of the new lung allocation system in the United States. Am J Transplant. 2006;6:1212.
Date H. Update on living-donor lobar lung transplantation. Curr Opin Organ Transplant. 2011;16:453–7.
Date H, Aoe M, Sano Y, Goto K, Kawada M, Shimizu N. Bilateral living-donor lobar lung transplantation. Multimedia manual of cardio-thoracic surgery. 2005 Jan 1;2005(0809).
Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745.
Barr ML, Starnes VA. Living Lobar Lung Transplantation. In: Sugarbaker DJ, Bueno R, Krasna MJ, Mentzer SJ, Zellos L, editors. Adult Chest Surgery. 2nd ed. New York: McGraw Hill; 2013.
Starnes VA, Bowdish ME, Woo MS, Barbers RG, Schenkel FA, Horn MV, et al. A decade of living lobar lung transplantation: recipient outcomes. J Thorac Cardiovascu Surg. 2004;127:114.
Wells WJ, Barr ML. The ethics of living donor lung transplantation. Thorac Surg Clin. 2005;15:519.
Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. New York: Oxford University Press; 2001.
Cohen RG, Barr ML, Starnes VA. . In: Shumway SJ, Shumway NE, editors. Lobar Pulmonary Transplantation. Thoracic Transplantation. Cambridge, MA: Blackwell Science; 1995.
Kojimma K, Kato K, Oto T, Mitsuhashi T, Shinya T, Sei T, Okumura Y, et al. Preoperative graft volume assessment with 3D-CT volumetry in living-donor lobar lung transplantations. Acta Med Okayama. 2011;65(4):265–8.
Camargo JJP, Irion KL, Marchiori E, Hochhegger B, Hochhegger B, Porto NS, Moraes BG, et al. Computed tomography measurement of lung volume in preoperative assessment for living donor lung transplantation: Volume calculation using 3D surface rendering in the determination of size compatibility. Pediatr Transplantation. 2009;13:429–39.
Cohen RG, Barr ML, Schenkel FA, DeMeester TR, Wells WJ, Starnes VA. Living-related donor lobectomy for bilateral lobar transplantation in patients with cystic fibrosis. Ann Thorac Surg. 57:1423–8.
Bowdish ME, Pessotto R, Barbers RG, Schenkel FA, Starnes VA, Barr ML. Long-term pulmonary function after living-donor lobar lung transplantation in adults. Ann Thorac Surg. 2005;79:418–25.
Egawa H, Tanabe K, Fukushima N, Date H, Sugitani A, Haga H. Current status of organ transplantation in Japan. Am J Transplant. 2012;12:523.
Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, et al. A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation. 2006;81:1373–85.
Yusen RD, Hong B, Murray SK, et al. Morbidity and mortality of 369 Live Lung Donors. Am J Transplant. 2011;11 Suppl 2:49.
Barr ML. 5UO1AI069545-05. http://projectreporter.nih.gov/project_info_description.cfm?aid=7899950&icde=11981871& ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cohen, R., Barr, M., Starnes, V. (2014). Living Donor Lung Transplantation. In: STEEL, J. (eds) Living Donor Advocacy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9143-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9143-9_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9142-2
Online ISBN: 978-1-4614-9143-9
eBook Packages: MedicineMedicine (R0)